Cytogenetic findings in 31 papillary thyroid carcinomas

Area of Science:

• Oncology
• Cytogenetics
• Molecular Biology

Background:

• Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy.
• Understanding the genetic alterations underlying PTC development is crucial for targeted therapies.
• Previous studies have identified various chromosomal abnormalities in PTC, but specific associations with histological variants require further investigation.

Purpose of the Study:

• To investigate the spectrum of numerical and structural chromosomal abnormalities in a cohort of papillary thyroid carcinomas.
• To identify potential correlations between specific chromosomal changes and distinct histological subtypes of PTC, particularly the tall-cell variant.

Main Methods:

• Karyotyping was performed on 31 papillary thyroid carcinoma (PTC) tumor samples.
• Analysis focused on identifying clonal numerical aberrations (e.g., trisomy, loss) and structural rearrangements (e.g., translocations, associations).
• Chromosomal findings were correlated with histological classifications, including the tall-cell variant.

Main Results:

• Clonal numerical and structural chromosomal abnormalities were detected in 12 out of 31 (38.7%) PTCs.
• Common numerical aberrations included trisomy 2, trisomy 7, and loss of the Y chromosome.
• A nonrandom telomeric association, tas(15;16)(p13;p13), was observed in one case.
• Structural alterations involving breakpoints at 10q11.2 were found in two tumors.
• Rearrangements involving chromosomes 1, 2, 3, 5, 7, 9, 11, 12, and 14 were also noted.
• Importantly, clonal changes of chromosome 2, specifically i(2)(q10) and trisomy 2, were identified in two tumors classified as tall-cell PTC variants.

Conclusions:

• The study identified a significant frequency of clonal chromosomal abnormalities in papillary thyroid carcinomas.
• The presence of trisomy 2 and gain of 2q in tall-cell PTC variants suggests a potential role for these genetic changes in the pathogenesis of this specific histological subtype.
• These findings may contribute to a better understanding of PTC heterogeneity and could inform future diagnostic or therapeutic strategies.